ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$19.74M	-
Other	Edwards Larry Todd	150.2K	$4.00M	-
Other	Matsuda Masaru	127.6K	$3.40M	-
Other	Burnett Patrick	120.2K	$3.21M	-
CFO	Vairavan Latha	86.0K	$2.29M	-

Activity

Buys and sells only

Transactions

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 6, 2023	Lock Kenneth A.71	Chief Commercial Officer	Sell	831	$15.26	$12,684.05	-1.3%	-41.1%	-25.0%
Mar 2, 2023	Moore Matthew Richard	See Remarks	Sell	1,610	$15.83	$25,481.25	-6.4%	-52.5%	-25.6%
Mar 2, 2023	Matsuda Masaru51	See Remarks	Sell	1,434	$15.83	$22,695.79	-3.8%	-52.5%	-25.6%
Mar 2, 2023	Burnett Patrick	See Remarks	Sell	1,751	$15.83	$27,713.12	-2.2%	-52.5%	-25.6%
Mar 2, 2023	Turney Patricia A.71	SVP, Operations	Sell	2,368	$15.96	$37,796.09	-1.7%	-52.5%	-25.6%
Mar 2, 2023	Watanabe Todd Franklin65	See Remarks	Sell	7,815	$15.93	$124,483.26	-0.7%	-52.5%	-25.6%
Mar 2, 2023	Burrows Scott L74	Chief Financial Officer	Sell	1,850	$15.90	$29,421.25	-1.6%	-52.5%	-25.6%
Mar 2, 2023	Lock Kenneth A.71	Chief Commercial Officer	Sell	2,368	$15.96	$37,795.95	-1.8%	-52.5%	-25.6%
Mar 2, 2023	Osborne David W76	Chief Technical Officer	Sell	2,005	$15.96	$32,002.07	-0.3%	-52.5%	-25.6%
Feb 15, 2023	Welgus Howard G.61	-	Sale+OE	8,500	$16.98	$144,352.10	-4.9%	-41.8%	-53.5%

← PrevPage 13Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC